Abstract
It has been shown, using the model of the chronic heart failure proceeded with induced decompensations, that the ACE inhibitors and β-adrenoblockers promoted at different degree the correction of hypercatecholaminemia and an increase of the rat survival. The β-adrenoblockers Atenolol, Propranolol and Carvedilol had the most effect. The remaining β-adrenoblockers, not possessing the inner sympathetic-mimetic activity, as well as Captopril, demonstrated the less activity. However the positive effect of these preparations occurred on the rat survival independent on the expression of their modulating effect on the sympathetic -adrenal system. The ACE inhibitors, especially the hydrophilic Lisinopril, prevent at less degree, than the β-adrenoblockers, the death of animals at the period of CHF exacerbation. A combine using of β-adrenoblockers with the ACE inhibitors, especially with the Carvedilol, promotes a maximally expressed decrease of the sympathetic-adrenal activity and an increase of the rat survival, especially at the period of CHF exacerbation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Boitsov, S.A., Central and Peripheral Mechanisms of Pathogenesis of the Chronic Heart Failure, Serdech. Nedostat., 2004, vol. 5, no. 2, pp. 92–93.
Swedberg, K., Eneroth, P., and Kjekshus, J., Hormones Regulating Cardiovascular Function in Patient with Severe Congestive Heart Failure and Their Relation to Mortality. CONSENSUS Trial Study Group, Circulation, 1990, vol. 82, pp. 1730–1736.
Sidorenko, B.A., Preobrazhenskii, D.V., and Batyraliev, T.A., Ingibitory angiotensin-prevrashchayushchego fermenta (Inhibitors of the Angio tensin-Converting Enzyme), Moscow, 2007.
Skvortsov, A.A. and Mareev, V.Yu., Beta-blockers in Chronic Heart Failure: Which Type of Block to Prefer?, Consilium medicum, 2001, vol. 3, no. 2, pp. 79–83
Inoko, M., Fujita, M., Nakae, I., Tamaki, Sh., Watanuki, M., Hashimoto, T., and Konishi, T., Effect of Angiotensin-Converting Enzyme Inhibition on Sympathetic Tone in Patients with Mild to Moderate Heart Failure, Jpn. Circ. J., 2001, vol. 65, pp. 395–398.
Mareev, V.Yu., Ageev, F.T., Arutyunov, A.G., Koroteev, A.V., and Revishvili, F.V., National recommendations WNOK and OSSN about Diagnostics and Treatment of CHF (the Third Revision), Serdech. Nedostat., 2010, vol. 11, no. 1 (57), pp. 3–62.
Pyatnitskii, N.N. and Blinkov, Yu.A., About Modeling of the Right Heart Failure, Kardiologiya, 1970, no. 1, pp. 143–144.
Fedorov, V.N., Yaltsev, A.V., Danilova, O.V., Sidorov, A.V., and Kataev, V.V., The Dynamic Model of the Total Chronic Heart Failure in Rats, Patol. Fiziol. Eksper. Terap., 2005, no. 3, pp. 7–9.
Rumyantseva, T.A., Fateev, M.M., Fedorov, V.N., Salnikov, E.V., and Sidorov, A.V., Mor pho logical Proofs of the Presence of Chronic Heart Failure Induced in Rats by the Method of Fractionary Dosed Oleothorax, Vest. Nizhegor. Un-ta, 2009, no. 5, pp. 123–127
Fedorov, V.N., Fateev, M.M., Salnikov, E.V., and Sidorov, A.V., Neurohumoral Mechanisms of Heart Adaptation in Rats to Overload, Zh. Evol. Biokhim. Fiziol., 2009, vol. 45, pp. 398–402
Guskova, T.A., Evaluation of Safety of the Medicinal Drugs at the Stage of the Preclinic Trials, Khimikofarmatsevtich. Zh., 1990, no. 7, pp. 10–15.
Osinskaya, V.O., Studies of Metabolism of Adrenalin and Noradrenalin in Tissues of the Animal Organism, Biokhimiya, 1977, no. 3, pp. 537–539.
Karsanov, N.V., Meliya, A.N., Sukoyan, G.V., Klimiashvili, Z.N., and Chikobaeva, E.A., Action of Refracterin on the Sympathoadrenal System in Chronic Heart Failure with the Ciliary Arrhythmia and without It, Ross. Kardiol. Zh., 2002, no. 4, pp. 28–35.
Olbinskaya, L.I. and Ignatenko, S.B., The Current Concept of Pathogenesis and Treatment of Chronic Heart Failure, Klinich. Medits., 2000, no. 8, pp. 22–27.
Belenkov, Yu.N., Mareev, V.Yu., and Ageev, F.T., Ingibitory angiotensin-prevrashchayushchikh fermentov pri lechenii serdechno-sosudistykh zabolevanii (kvinapril i endotelialnaya disfunktsiya) (Inhibitors of Angiotensin-Converting Enzymes in Treatment of Cardiovascular Diseases (Quinapril and the Endothelial Dysfunction), Moscow, 2002.
Lopatin, Yu.M., The Sympathicoadrenal System in Chronic Heart Failure: The Role in Pathogenesis and Possibility of Correction, Serdech. Nedostat., 2003, vol. 3, no. 1, pp. 20–21.
Baevskii, R.M. and Berseneva, A.P., Otsenka adaptatsionnykh vozmozhnosteii organizma i riska razvitiya zabolevanii (Evaluation of Adaptive Possibilities of Organism and of Risk of Development of Diseases), Moscow, 1997.
Kryzhanovskii, G.N., Disregulyatsionnaya patologiya (Disregulatory Pathology), Patol. Fiziol. Eksperim. Terap., 2002, no. 3, pp. 2–19.
Pribylova, N.N. and Osipova, O.A., Neurohumoral Mechanisms of Chronic Heart Failure in Patients with Postinfarction Cardiosclerosis, Serdech. Nedostat., 2009, vol. 10, no. 4, pp. 24–28.
Patel, K.P., Li, Y, and Hirooka, Y., Role of Nitric Oxide in Central Sympathetic Outflow, Experim. Biol. Med., 2001, vol. 226, pp. 814–824.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.V. Sidorov, M.M. Fateev, 2013, published in Zhurnal Evolyutsionnoi Biokhimii i Fiziologii, 2013, Vol. 49, No. 3, pp. 224–232.
Rights and permissions
About this article
Cite this article
Sidorov, A.V., Fateev, M.M. Effect of angiotensin-converting enzyme inhibitors, beta-adrenoblockers and their combinations on survival and blood plasma catecholamine levels in rats with chronic heart failure with induced exacerbations. J Evol Biochem Phys 49, 330–340 (2013). https://doi.org/10.1134/S0022093013030079
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0022093013030079